Alpha-1 patients donate samples to fuel future discoveries
NCT ID NCT00884455
First seen Jan 31, 2026 · Last updated May 20, 2026 · Updated 19 times
Summary
This study builds a long-term bank of medical information and tissue samples (blood, liver, lung) from people with Alpha-1 Antitrypsin Deficiency. Up to 5,000 participants can join, and there are no restrictions on who can enroll. The goal is to provide researchers with resources to better understand the disease, not to test any treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALPHA 1-ANTITRYPSIN DEFICIENCY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University of Florida
Gainesville, Florida, 32610, United States
Conditions
Explore the condition pages connected to this study.